Y54: Agents primarily affecting water-balance and mineral and uric acid metabolism

Y54.2: Carbonic-anhydrase inhibitors

Carbonic-anhydrase inhibitors are a type of medication that helps to manage conditions linked to an overproduction of fluid in the body. They work by reducing the activity of an enzyme called carbonic anhydrase, which is involved in the process of fluid production. This class of drugs is often used in the treatment of conditions such as glaucoma, a disease that increases pressure in the eye and can lead to vision loss if not properly managed. Additionally, they can help manage symptoms in conditions where there is excessive fluid retention in the body, like certain types of heart disease or kidney disorders. Like all medications, carbonic anhydrase inhibitors can carry potential side effects; these may include fatigue, increased urination, loss of appetite, or a metallic taste in the mouth. It's important to discuss any concerns about side effects with your healthcare provider.